Affinity-directed tagging of protein binding partners in signaling
信号传导中蛋白质结合伴侣的亲和定向标记
基本信息
- 批准号:8871699
- 负责人:
- 金额:$ 32.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-16 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAffinityApoptosisApoptosis InhibitorApoptoticBindingBiologicalBiologyCaspaseCell DeathCell ExtractsCellsCellular StructuresChemistryComplexDasatinibDevelopmentDevicesDiseaseEngineeringEnzymesFoundationsFutureGeneric DrugsGoalsHealthHomeostasisHomologous GeneHumanIn SituKnowledgeLifeLinkMapsMethodsMultiple MyelomaNamesNatureNecrosisPathway interactionsPharmaceutical PreparationsPhosphoric Monoester HydrolasesPhosphotransferasesPost-Translational Protein ProcessingProcessProtein BindingProtein EngineeringProteinsProteomeProteomicsResearchRoleSeaSignal PathwaySignal TransductionSomatropinSystemTechnologyThalidomideTherapeuticTimeUbiquitinUbiquitinationWalkingWorkbiological systemscell growth regulationdesignhuman GHR proteininterestnew technologynovelprotein complexprotein protein interactionreceptorsmall moleculetoolubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this proposal is to provide a more comprehensive understanding of signaling pathways and small molecules that impinge them. Mapping information flow in cells is critical to understanding cellular regulation in homeostasis, dysregulation in disease, and the impact of drugs in cells. Transient protein-protein interactions and post-translational modifications (PTMs) are key components of the information flow. However, identification of these interacting partners and especially those for post-translational modifying enzymes remains challenging due to their ephemeral nature and the vast numbers of PTMs in the cell. Current methods employing proteomics and affinity pull-downs are powerful tools for probing protein-protein interactions and PTMs, but these approaches have significant limitations. This proposal aims to address these challenges by engineering and optimizing a new catalytic tagging device, the NEDDylator, which tags its substrates with a stable, simple, and orthogonal mark allowing robust and quantitative identification by proteomics. Our hypothesis is that the NEDDylator technology will be generalizable to exemplary ubiquitin ligases, phosphatases, kinases, and small molecules that affect them, all of which are involved in regulated cell death. The approaches are three-fold: Specific Aim 1: Quantitative and mechanistic analysis of the NEDDylator. The rate-limiting steps and limitations of affinity and product inhibition will be determined for NEDDylation in three complexes: a natural E3-substrate pair, the well-characterized human growth hormone receptor protein complex, and the complex between the drug dasatinib and its target ABL. Specific Aim 2: Engineer the NEDDylator for use in living cells. A fully orthogonal and small molecule inducible NEDDylator will be designed for cellular studies and the proteomic workflow will also be simplified. Specific Aim 3: Elaborate important E3 signaling pathways using the NEDDylator in native proteomes. The NEDDylator will be applied to several pathways of important biological interest in cell death and disease. Information flow will be traced step-by-step through a pathway starting at ubiquitin ligases important for apoptosis and necrosis, and cereblon, a ubiquitin E3 ligase target of the multiple myeloma drug, thalidomide. E3 substrates will be identified and validated, and the NEDDylator will be attached to find their respective cellular binding partners. The proposed studies will validate and expand a novel catalytic tagging platform to dramatically augment the discovery of interacting proteins in extracts and cells. Compared to existing methods, this new technology covalently tags proteins in situ and will enable the discovery of transient as well as high-affinity interactions. The knowledge gained from these studies, both technically and biologically, will likely have a significant impact on our
understanding of molecular interactions between proteins and their binding partners in cells.
描述(由申请人提供):本提案的长期目标是提供对信号通路和影响它们的小分子的更全面的理解。绘制细胞中的信息流对于理解稳态中的细胞调节、疾病中的失调以及药物对细胞的影响至关重要。瞬时蛋白质-蛋白质相互作用和翻译后修饰(PTM)是信息流的关键组成部分。然而,这些相互作用的合作伙伴,特别是那些翻译后修饰酶的鉴定仍然具有挑战性,由于其短暂的性质和大量的PTM在细胞中。目前采用蛋白质组学和亲和力下拉的方法是探测蛋白质-蛋白质相互作用和PTM的有力工具,但这些方法具有显著的局限性。该提案旨在通过设计和优化一种新的催化标记装置NEDDylator来应对这些挑战,该装置用稳定,简单和正交的标记标记其底物,从而允许通过蛋白质组学进行稳健和定量鉴定。我们的假设是,NEDDylator技术将可推广到示例性的泛素连接酶、磷酸酶、激酶和影响它们的小分子,所有这些都参与调节性细胞死亡。具体目标1:NEDDylator的定量和机理分析。速率限制步骤和限制的亲和力和产品抑制将被确定为NEDD化在三个复合物:一个天然的E3-底物对,充分表征的人生长激素受体蛋白复合物,和药物达沙替尼和它的目标ABL. Specific目标2之间的复合物:工程的NEDD ylator用于活细胞。一个完全正交和小分子诱导的NEDDylator将被设计用于细胞研究,蛋白质组学工作流程也将被简化。具体目标3:在天然蛋白质组中使用NEDDylator详细阐述重要的E3信号通路。NEDDylator将应用于细胞死亡和疾病中具有重要生物学意义的几种途径。信息流将通过一个途径一步一步地追踪,该途径始于对细胞凋亡和坏死很重要的泛素连接酶,以及多发性骨髓瘤药物沙利度胺的泛素E3连接酶靶点cereblon。将鉴定并验证E3底物,并连接NEDDylator以找到其各自的细胞结合配偶体。拟议的研究将验证和扩展一种新的催化标记平台,以显着增加提取物和细胞中相互作用蛋白质的发现。与现有的方法相比,这项新技术原位共价标记蛋白质,将能够发现瞬时和高亲和力的相互作用。从这些研究中获得的知识,无论是技术上还是生物学上,都可能对我们的研究产生重大影响。
了解细胞中蛋白质及其结合伴侣之间的分子相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES A WELLS其他文献
JAMES A WELLS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES A WELLS', 18)}}的其他基金
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
基于新蛋白质工程的工具和技术,用于表征癌细胞中的细胞表面蛋白水解,以获得新型新表位生物标志物和药物靶点
- 批准号:
10582604 - 财政年份:2020
- 资助金额:
$ 32.88万 - 项目类别:
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
基于新蛋白质工程的工具和技术,用于表征癌细胞中的细胞表面蛋白水解,以获得新型新表位生物标志物和药物靶点
- 批准号:
10371980 - 财政年份:2020
- 资助金额:
$ 32.88万 - 项目类别:
Surfaceomic technologies and antibodies to probe cell surface proteomes and their interactomes at unprecedented small scale and high-resolution
表面组学技术和抗体以前所未有的小规模和高分辨率探测细胞表面蛋白质组及其相互作用组
- 批准号:
10552328 - 财政年份:2017
- 资助金额:
$ 32.88万 - 项目类别:
Discovering how oncogenes remodel the surfaceome of cells
发现癌基因如何重塑细胞表面组
- 批准号:
10212408 - 财政年份:2017
- 资助金额:
$ 32.88万 - 项目类别:
Affinity-directed tagging of protein binding partners in signaling
信号传导中蛋白质结合伴侣的亲和定向标记
- 批准号:
8628677 - 财政年份:2014
- 资助金额:
$ 32.88万 - 项目类别:
Renewable Antibodies for Post Translational Modifications and Protease Activatio
用于翻译后修饰和蛋白酶激活的可再生抗体
- 批准号:
8702418 - 财政年份:2014
- 资助金额:
$ 32.88万 - 项目类别:
Generation of recombinant thiopeptides to target antimicrobial-resistant bacteria
生成重组硫肽以靶向抗菌素耐药细菌
- 批准号:
8798574 - 财政年份:2014
- 资助金额:
$ 32.88万 - 项目类别:
Affinity-directed tagging of protein binding partners in signaling
信号传导中蛋白质结合伴侣的亲和定向标记
- 批准号:
9065515 - 财政年份:2014
- 资助金额:
$ 32.88万 - 项目类别:
Automated System for High-Throughput In Vitro Selection of Recombinant Antibodies
用于重组抗体高通量体外选择的自动化系统
- 批准号:
8247377 - 财政年份:2012
- 资助金额:
$ 32.88万 - 项目类别:
IDENTIFICATION OF PROTEOLYSIS-DEPENDENT EXECUTIONER CASPASE PROTEIN COMPLEXES
蛋白水解依赖性执行器 Caspase 蛋白复合物的鉴定
- 批准号:
8363836 - 财政年份:2011
- 资助金额:
$ 32.88万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 32.88万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 32.88万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 32.88万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 32.88万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 32.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 32.88万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 32.88万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 32.88万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 32.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 32.88万 - 项目类别:
Studentship